La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

MEDICLIN Bilan de santé

Santé financière contrôle des critères 3/6

MEDICLIN possède un total de capitaux propres de €198.5M et une dette totale de €92.7M, ce qui porte son ratio d'endettement à 46.7%. Son actif total et son passif total sont €889.6M et de €691.1M. L'EBIT de MEDICLIN est €37.2M ce qui fait que son ratio de couverture des intérêts 1.8. Elle dispose de liquidités et de placements à court terme de €113.5M.

Informations clés

46.7%

Ratio d'endettement

€92.71m

Dette

Ratio de couverture des intérêts	1.8x
Argent liquide	€113.46m
Fonds propres	€198.47m
Total du passif	€691.14m
Total des actifs	€889.61m

Mises à jour récentes de la santé financière

Recent updates

Pinning Down MEDICLIN Aktiengesellschaft's (ETR:MED) P/S Is Difficult Right Now

Mar 29

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

Oct 27

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

May 19

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

Feb 18

MEDICLIN's (ETR:MED) Stock Price Has Reduced 44% In The Past Three Years

Dec 07

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de MED ( €308.1M ) dépassent ses passifs à court terme ( €183.4M ).

Passif à long terme: Les actifs à court terme de MED ( €308.1M ) ne couvrent pas ses passifs à long terme ( €507.7M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: MED dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de MED est passé de 45.2% à 46.7% au cours des 5 dernières années.

Couverture de la dette: La dette de MED est bien couverte par le flux de trésorerie opérationnel ( 84.4% ).

Couverture des intérêts: Les paiements d'intérêts de MED sur sa dette ne sont pas bien couverts par l'EBIT ( 1.8 x couverture).

MEDICLIN Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

Recent updates

Now 20% undervalued after recent price drop

Second quarter 2024 earnings released: EPS: €0.01 (vs €0.23 in 2Q 2023)

First quarter 2024 earnings released: €0.03 loss per share (vs €0.13 loss in 1Q 2023)

Pinning Down MEDICLIN Aktiengesellschaft's (ETR:MED) P/S Is Difficult Right Now

MEDICLIN Aktiengesellschaft, Annual General Meeting, Jun 06, 2024

Full year 2023 earnings released: €0.23 loss per share (vs €0.20 profit in FY 2022)

MEDICLIN Aktiengesellschaft to Report Fiscal Year 2023 Final Results on Mar 26, 2024

Now 22% undervalued

MEDICLIN Aktiengesellschaft to Report First Half, 2024 Results on Jul 31, 2024

Third quarter 2023 earnings released: EPS: €0.22 (vs €0.043 in 3Q 2022)

MEDICLIN Aktiengesellschaft Appoints Thomas Piefke as A Member of Management Board. Effective October 1, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: €0.23 (vs €0.13 in 2Q 2022)

First quarter 2023 earnings released: €0.13 loss per share (vs €0.081 loss in 1Q 2022)

Mercurius Health, S.A. completed the acquisition of MEDICLIN Robert Janker Klinik from MEDICLIN Aktiengesellschaft.

MEDICLIN Aktiengesellschaft to Report Nine Months, 2023 Results on Nov 03, 2023

Now 20% undervalued

Price target increased to €6.10

Now 20% undervalued

Investor sentiment improved over the past week

Here's Why MEDICLIN (ETR:MED) Has A Meaningful Debt Burden

Second quarter 2022 earnings released: €0.13 loss per share (vs €0.08 loss in 2Q 2021)

MEDICLIN Aktiengesellschaft Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: €0.08 loss per share (vs €0.24 loss in 1Q 2021)

Full year 2021 earnings released: EPS: €0.03 (vs €0.19 loss in FY 2020)

MEDICLIN Aktiengesellschaft to Report Fiscal Year 2021 Results on Mar 30, 2022

Third quarter 2021 earnings released: EPS €0.22 (vs €0.14 in 3Q 2020)

Chairman of Management Board & CEO Volker Hippler has left the company

Second quarter 2021 earnings released: €0.08 loss per share (vs €0.12 loss in 2Q 2020)

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

MEDICLIN AG Provides Earnings Guidance for the Year 2021

MEDICLIN (ETR:MED) Has Debt But No Earnings; Should You Worry?

New 90-day high: €4.42

Mediclin AG Appoints York Dhein as Additional Member to the Management Board, Effective April 1, 2021

New 90-day high: €4.00

MEDICLIN's (ETR:MED) Stock Price Has Reduced 44% In The Past Three Years

MEDICLIN Aktiengesellschaft, Annual General Meeting, May 27, 2021

Third quarter 2020 earnings released: EPS €0.12

MEDICLIN Aktiengesellschaft to Report Q1, 2021 Results on May 03, 2021

New 90-day low: €3.70

MediClin AG Announces Reliable Forecast for the 2020 Financial Year Is Not Yet Possible

District of Ludwigslust-Parchim signed a letter of intent to acquire an unknown stake in MediClin Krankenhaus am Crivitzer See GmbH from MEDICLIN Aktiengesellschaft (XTRA:MED).

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines